{
  "image_filename": "table_p1_mrg_det_0_017.png",
  "image_path": "FlublokPI/extracted/figures/table_p1_mrg_det_0_017.png",
  "image_type": "Table",
  "page_number": 1,
  "block_id": "mrg_det_0_017",
  "claim_id": "claim_003",
  "claim": "Recombinant technology leads to a broader immune response that may provide cross-protection, even in a mismatch season.",
  "supports_claim": false,
  "explanation": "A table of contents from the full prescribing information for Flublok vaccine, listing section headings such as Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology, Clinical Studies, etc. The image only shows the table of contents and provides no data on immune responses, recombinant technology, or cross-protection; it does not support the claim Note: Analysis limited to a table of contents without study data; no direct immunogenicity information is present",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table of contents from the full prescribing information for Flublok vaccine, listing section headings such as Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology, Clinical Studies, etc.",
    "evidence_found": null,
    "reasoning": "The image only shows the table of contents and provides no data on immune responses, recombinant technology, or cross-protection; it does not support the claim",
    "confidence_notes": "Analysis limited to a table of contents without study data; no direct immunogenicity information is present"
  }
}